Quinazolinone derivatives and their use as CB agonists

Details for Australian Patent Application No. 2007202781 (hide)

Owner Novartis AG

Inventors Brain, Christopher Thomas; Hart, Terance William; Dziadulewicz, Edward Karol

Agent Davies Collison Cave

Pub. Number AU-B-2007202781

Parent 2003210212

Filing date 15 June 2007

Wipo publication date 5 July 2007

Acceptance publication date 9 September 2010

International Classifications

C07D 239/91 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/5377 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/06 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

5 July 2007 Application Open to Public Inspection

  Published as AU-B-2007202781

5 July 2007 Complete Application Filed

9 September 2010 Application Accepted

  Published as AU-B-2007202781

13 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007202782-Startup and control of graph-based computation

2007202780-Kettle Lid Dampening Mechanism